Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2025 -1.579M
December 31, 2024 -1.066M
June 30, 2024 -2.406M
December 31, 2023 -0.6209M
June 30, 2023 2.422M
December 31, 2022 2.640M
June 30, 2022 2.458M
December 31, 2021 1.080M
June 30, 2021 1.153M
December 31, 2020 2.035M
June 30, 2020 1.019M
December 31, 2019 0.0214M
June 30, 2019 -0.2575M
December 31, 2018 -0.6857M
June 30, 2018 -0.1898M
December 31, 2017 -2.121M
June 30, 2017 -3.444M
December 31, 2016 -2.739M
June 30, 2016 -3.133M
December 31, 2015 -3.592M
June 30, 2015 -4.524M
Date Value
December 31, 2014 -5.383M
June 30, 2014 -5.338M
December 31, 2013 -4.323M
June 30, 2013 -4.806M
December 31, 2012 -5.300M
June 30, 2012 -6.064M
December 31, 2011 -8.255M
June 30, 2011 4.746M
December 31, 2010 6.374M
June 30, 2010 -5.173M
December 31, 2009 -4.606M
June 30, 2009 -6.850M
December 31, 2008 -7.471M
June 30, 2008 -7.816M
December 31, 2007 -8.184M
June 30, 2007 -7.859M
December 31, 2006 -6.742M
June 30, 2006 -6.426M
December 31, 2005 -8.424M
June 30, 2005 -7.832M
December 31, 2004 -6.904M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Ixico Plc -2.718M
Oxford BioDynamics Plc -10.10M
ICON plc 1.083B
Champions Oncology, Inc. -5.564M
Silence Therapeutics Plc -41.79M